JILLIAN KEARNEY: Open Payments
NPI 1255077558 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,548 in 63 payments from 25 companies in 2025. Trend: 2023 $2,117 · 2024 $1,949 · 2025 $1,548
Food & beverage: $1,448Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $243 |
| AstraZeneca Pharmaceuticals LP | 5 | $192 |
| Janssen Biotech, Inc. | 8 | $177 |
| Daiichi Sankyo Inc. | 10 | $142 |
| Merck Sharp & Dohme LLC | 4 | $102 |
| SEAGEN INC. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| Astellas Pharma US Inc | 2 | $61 |
| Genentech USA, Inc. | 2 | $52 |
| EMD Serono, Inc. | 2 | $45 |
Products named: SARCLISA, KEYTRUDA, DATROWAY, RYBREVANT, ERLEADA, Enhertu, IMFINZI, LIBTAYO.
Industry payments across NY — which companies pay providers there.
